Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.
Mireille M Doat, Richard A. Rabin, Jerrold C Winter
Pharmacology, Biochemistry, and Behavior February 2003 DOI: 10.1016/s0091-3057(02)01074-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental animal study Peer reviewed |
|---|---|
| Population | Male Fischer 344 rats trained to discriminate (-)-DOM or LSD from saline |
| Interventions | (-)-DOM LSD |
| Topics | LSD |
| Key findings | Intracerebroventricular administration of (-)-DOM and LSD produced faster onset and higher potency (2.4- and 1.5-fold, respectively) than systemic administration, supporting central mediation of their stimulus effects. |
Abstract
Despite the plausible assumption that the effects of hallucinogens predominantly arise in the central nervous system, most studies of these drugs in intact subjects have been conducted following systemic administration. The objective of the present investigation was to characterize the stimulus effects of (-)2,5-dimethoxy-4-methylamphetamine ((-)-DOM) following intracerebroventricular administration. Chronic indwelling cannulae were implanted into the lateral ventricle of male Fischer 344 rats trained to discriminate systemically administered (-)-DOM or lysergic acid diethylamide (LSD) from saline. Time-course and dose-response relationships for (-)-DOM and LSD administered intracerebroventricularly were established. For both LSD and (-)-DOM, central administration did not change the pretreatment times required for the maximal stimulus effects to occur. However, the onset of the stimulus effect was more rapid following intracerebroventricular administration. Following pretreatment periods that maximize drug-appropriate responding, central administration of (-)-DOM and LSD was approximately 2.4- and 1.5-times more potent, respectively, than systemic administration. The results of this study are consistent with the assumption that the stimulus effects of (-)-DOM and LSD are centrally mediated.
Comparable studies
Other preclinical and animal studies on LSD, most cited first.
Citations in the library
Cited by 5
- Animal Models of Serotonergic Psychedelics ACS Chemical Neuroscience September 24, 2012
- Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats Psychopharmacology July 1, 2009
- 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. Journal of Pharmacology and Experimental Therapeutics February 2007
- The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology October 2005
- Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology July 2005
Cites 9
- Role of serotonin in the discriminative stimulus properties of mescaline Pharmacology, Biochemistry, and Behavior May 1, 1975
- Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli Psychopharmacology 1971
- Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride Pharmacology, Biochemistry, and Behavior August 1, 1984
- A sensitive method for determining levels of [-]-2,5,-dimethoxy-4-methylamphetamine in the brain tissue. Journal of pharmacological and toxicological methods 2001
- The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis. Psychopharmacology October 1995
and 4 more in the library